A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer

NCT02991911 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration Resistant Prostate Cancer

Interventions

BIOLOGICAL: MEDI3726 Post-Chemo
BIOLOGICAL: MEDI3726 Pre-Chemo
BIOLOGICAL: MEDI3726 & Enzalutamide Combo

Sponsor

MedImmune LLC